as of 02-06-2026 3:46pm EST
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MOUNTAIN VIEW |
| Market Cap: | 2.4B | IPO Year: | 2025 |
| Target Price: | $39.20 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.38 - $41.22 | Next Earning Date: | 03-27-2026 |
| Revenue: | $161,881,000 | Revenue Growth: | 85.70% |
| Revenue Growth (this year): | 40.42% | Revenue Growth (next year): | 22.73% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -60923000.0 | FCF Growth: | N/A |
See how HTFL stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "HTFL Heartflow Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.